Sixteen of twenty (80%) of CRPS patients treated with ketamine infusions for refractory pain experienced transient elevations in lever enzyme (AST, ALT, GGT) levels that decreased back to baseline within 10–14 days following treatment (Kiefer et al., 2008). This evidence concerns the gene GPT and complex regional pain syndrome.